Table 3 Correlation between nuclear, cytoplasmic CARM1 expression and molecular subtypes of breast cancer patients
Molecular subtypes | n | Nuclear CARM1 expression | P* | Cytoplasmic CARM1 expression | P * | ||
|---|---|---|---|---|---|---|---|
Negative or low expression (IHC score < 80) | High or over expression (IHC score ≥ 80) | Negative or low expression (IHC score < 80) | High or over expression (IHC score ≥ 80) | ||||
Lumina A | 121 | 71 (58.7) | 50 (41.3) | 0.019 | 60 (49.6) | 61 (50.4) | 0.066 |
Luminal B | 47 | 19 (40.4) | 28 (59.6) | Â | 19 (40.4) | 28 (59.6) | Â |
HER2 type | 23 | 7 (30.4) | 16 (69.6) | Â | 5 (21.7) | 18 (78.3) | Â |
triple negative | 56 | 24 (42.9) | 32 (57.1) | Â | 21 (37.5) | 35 (62.5) | Â |